user

Real-Life Intracerebral Efficacy of Nivolumab in Non-Small Cell Lung Cancer Patients with Brain Metastases

被引：9
|
作者：
Geier, M. [1 ]
Descourt, R. [1 ]
Corre, R. [2 ]
Leveiller, G. [3 ]
Lamy, R. [4 ]
Goarant, E. [5 ]
Bizec, J. [6 ]
Bernier, C. [7 ]
Quere, G. [8 ]
Couturaud, F. [1 ]
Robinet, G. [1 ]
机构：
[1] Univ Hosp Brest, Dept Oncol, Chru Morvan, Brest, France
[2] CHU Rennes, Rennes, France
[3] Hosp St Brieuc, Dept Pulm Dis, Ch Yves Le Foll, St Brieuc, France
[4] Ctr Hosp Bretagne Sud Lorient, Lorient, France
[5] Hosp St Malo, Dept Pulm Dis, St Malo, France
[6] Hosp Vannes, Ch Bretagne Atlantique, Vannes, France
[7] Hosp Dinan, Ch Rene Pleven, Dinan, France
[8] Hop Morvan, Chru Brest, Brest, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
brain metastases; efficacy; Nivolumab;
D O I：
10.1016/j.jtho.2018.08.383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.10
引用
收藏
页码：S384 / S385
页数：2
相关论文
共 50 条
  • [31] Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS)
    Ansel, S.
    Rulach, R.
    Clark, B.
    Steele, N.
    Maclaren, V.
    LUNG CANCER, 2018, 115 : S35 - S36
  • [32] IMPACT OF BRAIN METASTASES ON QUALITY OF LIFE AND ESTIMATED LIFE EXPECTANCY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Roughley, A.
    Damonte, E.
    Taylor-Stokes, G.
    Rider, A.
    Munk, V. C.
    VALUE IN HEALTH, 2014, 17 (07) : A650 - A650
  • [33] Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.
    Karabou, Abdoulaye
    Bisseux, Laurence
    Pavese, Ida
    Collon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Efficacy and Safety of Immune Checkpoint Inhibitors in Treating Brain Metastases in Patients With Non-small Cell Lung Cancer
    Teng, F.
    Sun, D.
    Xing, P.
    Hao, X.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S385 - S385
  • [35] IMPACT OF STEROIDS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES
    Thapa, Bicky
    Lauko, Adam
    Borghei-Razavi, Hamid
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Pennell, Nathan
    Velcheti, Vamsidhar
    Angelov, Lilyana
    Mohammadi, Alireza
    Vogelbaum, Michael
    Barnett, Gene
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2018, 20 : 55 - 55
  • [36] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [37] Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases.
    Ichiki, Masao
    Yoshida, Tsukasa
    Nakamura, Masayuki
    Kumano, Tomomi
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Kevin C. De Braganca
    Yelena Y. Janjigian
    Christopher G. Azzoli
    Mark G. Kris
    Maria C. Pietanza
    Craig P. Nolan
    Antonio M. Omuro
    Andrei I. Holodny
    Andrew B. Lassman
    Journal of Neuro-Oncology, 2010, 100 : 443 - 447
  • [39] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    De Braganca, Kevin C.
    Janjigian, Yelena Y.
    Azzoli, Christopher G.
    Kris, Mark G.
    Pietanza, Maria C.
    Nolan, Craig P.
    Omuro, Antonio M.
    Holodny, Andrei I.
    Lassman, Andrew B.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (03) : 443 - 447
  • [40] Prospective Evaluation of Ipilimumab and Nivolumab in Patients with Non-Small Cell Lung Cancer Brain Metastasis
    Juloori, A.
    Bestvina, C.
    Pitroda, S.
    Pointer, K.
    Jelinek, M.
    Hoffman, P.
    Vokes, E.
    Patel, J.
    Chmura, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S45 - S45
12345